You may have witnessed the excitement surrounding the new classes of medications being used for weight loss: GLP-1 receptor agonists, like Wegovy and Ozempic, and the newer, dual action (GLP1/GIP) medications like Mounjaro and Zepbound
GLP-1s slow gastric emptying, keeping food in the stomach longer to promote fullness
Practical strategies for staying on treatment long-term Committing to years of weekly injections requires systems and strategies beyond just filling your prescription
Local GI Effects: For applications related to gut lining, oral administration may provide direct topical contact with intestinal tissues in theory
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways GLP-1 agonists like Wegovy and Zepbound, lipase inhibitors such as Xenical and Alli, phentermine, and combination medications like Qsymia and Contrave are medications that may help aid in weight loss
In clinical trials, AOD 9604 has been shown to: Target belly fat reserves and burning fat without breaking down lean muscle Predominantly trigger fat release from obese fat cells Improve fat metabolism and weight reduction over time Most patients report gradual but steady results, with the best outcomes occurring when AOD 9604 is combined with exercise and medical weight loss supervision